ARC’s analysis of the 2026 Medicare Advantage landscape finds that the market remains stable and well funded. Plan availability and benefit generosity continue to be near all-time highs, even as […]
ARC performed an analysis of premiums in the stand-alone Medicare prescription drug plan (PDP) market between 2023 and 2025 using a combination of publicly available information on plans, premiums, and enrollment and using […]
ARC has updated its April 8th brief – which used the results of research by Keith Drake and Thomas G. McGuire included in a working paper – to include changes […]
CMS has released the first reconciliation results for the Innovation Center’s Enhancing Oncology Model (EOM), which showed that over three-quarters of participants generated cost savings and over half were rewarded for quality of […]
ARC annually develops an auxiliary data set for the Department of Labor that appends to the March Current Population Survey (CPS). While the March CPS is the data source most often used for […]
Earlier this month, the Medicare Payment Advisory Commission (MedPAC) published its latest Report to the Congress.
Among the recommendations for revising the Medicare Physician Fee Schedule and related policies, the Commission […]